Ozempic compounding ban no ‘knee-jerk’ reaction

Department defends recommendation to ban the compounding of semaglutide and tirepatide medications  Moves to prohibit pharmacists from compounding replicas of Ozempic (semaglutide) and Mounjaro (tirepatide) were not a “knee-jerk response” to a story by the ABC, a Department of Health and Aged Care official says.  Speaking during a Senate Estimates hearing earlier this month (5